Editorial. Reducing the burden of spine fusion.

08:00 EDT 1st April 2019 | BioPortfolio

Summary of "Editorial. Reducing the burden of spine fusion."

No Summary Available


Journal Details

This article was published in the following journal.

Name: Neurosurgical focus
ISSN: 1092-0684
Pages: E15


DeepDyve research library

PubMed Articles [8333 Associated PubMed Articles listed on BioPortfolio]

Lumbar spine fusion: what is the evidence?

Lumbar spine fusion is a common procedure associated with a high cost burden and risk of serious complications. We aimed to summarise systematic reviews on the effectiveness of lumbar spine fusion for...

Evaluation of bony fusion after anterior cervical discectomy: a systematic literature review.

Anterior cervical discectomy and fusion (ACDF) has proven effective in treating radicular arm pain. Post-operatively, cervical spine stability is temporarily challenged, but data on bony fusion and sp...

A validated preoperative score for predicting 30-day readmission after 1-2 level elective posterior lumbar fusion.

To develop a model to predict 30-day readmission rates in elective 1-2 level posterior lumbar spine fusion (PSF) patients.

Selective Blocking Laminoplasty in Cervical Laminectomy and Fusion to Prevent Postoperative C5 Palsy.

Cervical laminectomy and fusion (CLF) is a common surgical option for multi-level cord compression. Postoperative C5 palsy occurrence after CLF has been a vexing problem for spine physicians. The post...

Is Teriparatide Beneficial to Spinal Fusion Surgery in the Older Patient?: A Narrative Review.

Since FDA approval in 2002, teriparatide has gained popularity as an anabolic therapy for the treatment of osteoporosis. Animal studies have suggested a role for teriparatide in spine surgery. Several...

Clinical Trials [4647 Associated Clinical Trials listed on BioPortfolio]

Understanding Non-Response in Spine Fusion Surgery

To identify patient characteristics associated with non-response after spine fusion surgery for the treatment of degenerative disc disease (DDD).

Postoperative subQ Pain Control for Spinal Fusion Surgery

Post-operative pain following lumbar spine fusion is frequently difficult to manage and can lead to increased doses of opiate pain medications to control pain. In this study, the use of su...

A Prospective, Multicenter Observational Study on MAST™ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar Spine

The aim of the study is to observe and document surgical practice and evaluate patients' outcomes following a MAST™ single or double level instrumented fusion procedure using PLIF (Poste...

Sagittal Parameters After Mono Segmental Lumber Fusion: Interbody Versus Postrolateral Fusion

To compare postoperative radiographic sagittal parameters after monosegmental lumbar fusion: posterior lumbar interbody fusion versus postrolateral fusion in treatment of lumbar spine inst...

Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion

The hypothesis is that Aastrom TRC autologous bone marrow tissue "grafts" can be safely used to promote bone healing as part of a single level posterolateral spine fusion surgical procedur...

Medical and Biotech [MESH] Definitions

The guidelines and policy statements set forth by the editor(s) or editorial board of a publication.

Measure of the burden of disease using the disability-adjusted-life-year (DALY). This time-based measure combines years of life lost due to premature mortality and years of life lost due to time lived in states of less than full health. The metric was developed to assess the burden of disease consistently across diseases, risk factors and regions.

Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc.

The GENETIC RECOMBINATION of the parts of two or more GENES resulting in a gene with different or additional regulatory regions, or a new chimeric gene product. ONCOGENE FUSION includes an ONCOGENE as at least one of the fusion partners and such gene fusions are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS. ARTIFICIAL GENE FUSION is carried out in vitro by RECOMBINANT DNA technology.

The GENETIC RECOMBINATION of the parts of two or more GENES, including an ONCOGENE as at least one of the fusion partners. Such gene fusions are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS.

Quick Search


DeepDyve research library

Searches Linking to this Article